News
Glaxo, Alphabet Plan $700 Million Bioelectric Treatment Venture
August 2, 2016/
GlaxoSmithKline PLC and Google parent Alphabet Inc. have teamed up to develop what they call bioelectronic medicines, or treatments that use miniature implanted electronic devices to modify how electrical impulses are transmitted around the nervous system.
By Denise Roland
Full Story: http://www.wsj.com/articles/glaxo-alphabet-plan-700-million-bioelectric-treatment-venture-1470035507



